Correspondingly, our findings revealed that eIF3a expression was obviously increased in DLBCL, and has a close linkage with IPI score and Ann-Arbor stage, suggesting that eIF3a may be related to the progression of DLBCL. This evidence concerns the gene EIF3A and diffuse large B-cell lymphoma.